• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Soleno Therapeutics (SLNO)

Common Shares
Sell: $37.42|Buy: $40.00|Change: 1.42 (-3.55%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Address

203 Redwood Shores Parkway
Suite 500
Redwood City
CA
USA
94065

Telephone

+1 650 213-8444

Website

https://www.soleno.life

Sector 

Healthcare

Forecast key dates

NameKey Date
Soleno Therapeutics Inc Fourth Quarter Earnings Conference Call for 20262027-02-25T16:30:00
Soleno Therapeutics Inc Fourth Quarter Earnings Results for 20262027-02-25T00:00:00
Soleno Therapeutics Inc Third Quarter Earnings Conference Call for 20262026-11-04T16:30:00
Soleno Therapeutics Inc Third Quarter Earnings Results for 20262026-11-04T00:00:00
Soleno Therapeutics Inc Second Quarter Earnings Conference Call for 20262026-08-06T16:30:00
Soleno Therapeutics Inc Second Quarter Earnings Results for 20262026-08-06T00:00:00
Soleno Therapeutics Inc Annual General Meeting for 20262026-06-05T08:00:00
Soleno Therapeutics Inc First Quarter Earnings Conference Call for 20262026-05-07T16:30:00
Soleno Therapeutics Inc First Quarter Earnings Results for 20262026-05-07T00:00:00
TD Cowen 46th Annual Health Care Conference2026-03-04T09:50:00
Soleno Therapeutics Inc Annual Report for 20252026-02-27T00:00:00
Oppenheimer 36th Annual Healthcare Life Sciences Conference2026-02-26T10:00:00
Soleno Therapeutics Inc Fourth Quarter Earnings Conference Call for 20252026-02-25T16:30:00
Soleno Therapeutics Inc Fourth Quarter Earnings Result for 20252026-02-25T00:00:00
Guggenheim Emerging Outlook: Biotech Summit 20262026-02-12T11:30:00

Previous key dates

NameKey Date
Soleno Therapeutics Inc Annual Report for 20252026-02-27T00:00:00
Oppenheimer 36th Annual Healthcare Life Sciences Conference2026-02-26T10:00:00
Soleno Therapeutics Inc Fourth Quarter Earnings Conference Call for 20252026-02-25T16:30:00
Soleno Therapeutics Inc Fourth Quarter Earnings Result for 20252026-02-25T00:00:00
Guggenheim Emerging Outlook: Biotech Summit 20262026-02-12T11:30:00
Piper Sandler 37th Annual Healthcare Conference2025-12-04T09:00:00
Jefferies London Healthcare Conference2025-11-18T12:00:00
Stifel 2025 Healthcare Conference2025-11-12T08:40:00
Guggenheim Securities Healthcare Innovation Conference2025-11-11T09:00:00
Soleno Therapeutics Inc Third Quarter Earnings Conference Call for 20252025-11-04T16:30:00
Soleno Therapeutics Inc Third Quarter Earnings Result for 20252025-11-04T00:00:00
Wells Fargo Healthcare Conference2025-09-04T13:30:00
Cantor Global Healthcare Conference2025-09-03T13:00:00
Soleno Therapeutics Inc Second Quarter Earnings Conference Call for 20252025-08-06T16:30:00
Soleno Therapeutics Inc Second Quarter Earnings Result for 20252025-08-06T00:00:00
Goldman Sachs 46th Healthcare Conference2025-06-10T08:40:00
Soleno Therapeutics Inc Annual General Meeting for 20252025-06-05T08:00:00
Jefferies Global Healthcare Conference2025-06-04T10:30:00
Soleno Therapeutics Inc First Quarter Earnings Conference Call for 20252025-05-07T16:30:00
Soleno Therapeutics Inc First Quarter Earnings Result for 20252025-05-07T00:00:00
Soleno Update Call2025-03-26T17:30:00
Soleno Therapeutics Inc Annual Report for 20242025-02-28T00:00:00
Soleno Therapeutics Inc Fourth Quarter Earnings Results for 20242025-02-27T00:00:00
Oppenheimer 35th Annual Healthcare Life Sciences Conference2025-02-11T14:40:00
Guggenheim SMID Cap Biotech Conference2025-02-06T14:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.